Reading this on a mobile device? Try our optimized mobile version here:

March 19, 2013
More than 2,700 companies nationwide are saving on lab supplies, shipping, news distribution, office products and more through the BIO Business Solutions cost-savings program. Find out how.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
White Paper: Improving Total Cost of Ownership with EQMS
Companies are looking for ways to improve product quality, customer satisfaction and profitability while dealing with rising costs, competition and regulatory pressures. This white paper details how utilizing an EQMS backbone enables a broader organizational view of these issues, allowing for increased revenues and margins, operational efficiencies and global standardization for stakeholders. Read it now!
  Health Care & Policy 
  • Novartis' lung cancer drug gets breakthrough designation
    The FDA granted breakthrough therapy status to Novartis' LDK378 for treatment of patients with anaplastic lymphoma kinase positive metastatic nonsmall-cell lung cancer when crizotinib can't be used. The drug is being tested in two midstage trials, and Novartis plans to initiate several late-stage studies this year. An initial regulatory application is expected early next year. PharmaTimes (U.K.) (3/18) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • AstraZeneca consolidates its drug development work
    AstraZeneca plans to restructure its research and development operations to bring together drug development activities in three major facilities in the U.S., England and Sweden. A Gaithersburg, Md., facility will become the main hub for biotech research. The changes, meant to cut costs and increase productivity, will eliminate about 1,600 positions. Reuters (3/18), USA Today/The Associated Press (3/18) LinkedInFacebookTwitterEmail this Story
  Global Developments 

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or 

  Food & Agriculture 
  • Biotech potato trial planned in Ireland
    Irish researchers plan to begin a field trial of more than 2,000 blight-resistant potatoes in Carlow, Ireland. A strain known as A15-031 was developed by researchers at Wageningen University using donor genes from wild potato species in Mexico and Argentina. The Washington Post (3/16) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • Chinese steelmaker, U.S. firm team up for $70M ethanol project
    China's Tangshan Iron and Steel Group and U.S.-based industrial service firm Harsco have agreed to cooperate to produce ethanol using gas discharged from steel mills in China. Under the deal, the two companies will develop a $70 million facility with the capacity to produce 30,000 metric tons of ethanol annually. China Daily (Beijing) (3/15) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • Ship with FedEx
    FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

You may have to fight a battle more than once to win it."
--Margaret Thatcher,
British prime minister

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information